K E Langley
Impact in
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
- Immunology top 5%
- Mast cells and histamine
- T-cell and B-cell Immunology
Papers in
-
- Protease and Inhibitor Mechanisms 7
-
- Hematopoietic Stem Cell Transplantation 5
- Co-authors
- K M Zsebo (5 shared papers)Yves Albert DeClerck (4 shared papers)Shirley M. Taylor (1 shared paper)Thomas C. Boone (1 shared paper)Hiroyuki Shimada (1 shared paper)Yves A. De Clerck (2 shared papers)A.V. Fowler (2 shared papers)Irving Zabin (2 shared papers)
- Journals
- Blood (5 papers)Journal of Biological Chemistry (3 papers)The Journal of Immunology (2 papers)Biochemical Journal (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesGermany
In The Last Decade
K E Langley
19 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 88
- Cancer Research 763
- Immunology 514
- Hematology 355
- Oncology 197
- Molecular Biology 376
Countries citing papers authored by K E Langley
This map shows the geographic impact of K E Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K E Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K E Langley more than expected).
Fields of papers citing papers by K E Langley
This network shows the impact of papers produced by K E Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K E Langley. The network helps show where K E Langley may publish in the future.
Co-authors
The 25 scholars most cited alongside K E Langley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. | 1992 | 384 |
| 2 | 1991 | 356 | |
| 3 | 1991 | 187 | |
| 4 | 1989 | 182 | |
| 5 | 1975 | 166 | |
| 6 | 1991 | 140 | |
| 7 | Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. | 1996 | 130 |
| 8 | 1991 | 127 | |
| 9 | 1993 | 124 | |
| 10 | 1993 | 107 | |
| 11 | Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. | 1993 | 96 |
| 12 | 1988 | 61 | |
| 13 | 1993 | 57 | |
| 14 | 1995 | 57 | |
| 15 | 1995 | 57 | |
| 16 | 1975 | 51 | |
| 17 | 1996 | 41 | |
| 18 | 1990 | 24 | |
| 19 | FRAGMENTATION OF HUMAN POLYMORPHONUCLEAR-LEUKOCYTE COLLAGENASE | 1993 | 1 |
About K E Langley
K E Langley is a scholar working on Cancer Research, Hematology, Immunology, Biotechnology and Oncology, having authored 19 papers that have together received 2.3k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), Hematopoietic Stem Cell Transplantation (5 papers), Mast cells and histamine (5 papers), Enzyme Production and Characterization (2 papers), Bacterial Genetics and Biotechnology (2 papers), Enzyme Structure and Function (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Escherichia coli research studies (1 paper). The work is most often cited by research in Cancer Research (763 citations), Immunology (514 citations), Hematology (355 citations), Oncology (197 citations) and Molecular Biology (376 citations). K E Langley has collaborated with scholars based in United States and Germany. Frequent co-authors include K M Zsebo, Yves Albert DeClerck, Shirley M. Taylor, Thomas C. Boone, Hiroyuki Shimada, Yves A. De Clerck, A.V. Fowler, Irving Zabin, E N Geissler and Dean D. Metcalfe. Their work appears in journals such as Blood, Journal of Biological Chemistry, The Journal of Immunology, Biochemical Journal and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.